PTJ
IGMS

Paul Tudor Jones’s IGM Biosciences IGMS Stock Holding History

Paul Tudor Jones’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,537
Closed -$99.9K – 2901
2024
Q2 		$99.9K Buy
+14,537
New +$124K ﹤0.01% 2205
2023
Q4 		– Sell
-14,486
Closed -$121K – 2593
2023
Q3 		$121K Buy
14,486
+3,145
+28% +$26.7K ﹤0.01% 2137
2023
Q2 		$105K Sell
11,341
-3,156
-22% -$35.4K ﹤0.01% 2291
2023
Q1 		$199K Buy
+14,497
New +$300K ﹤0.01% 2179
2022
Q2 		– Sell
-14,639
Closed -$391K – 2295
2022
Q1 		$391K Buy
+14,639
New +$273K 0.01% 1409
2021
Q1 		– Sell
-3,683
Closed -$325K – 1703
2020
Q4 		$325K Buy
+3,683
New +$259K 0.01% 1097

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paul Tudor Jones's IGMS Position: Q3 2024 in Review

Paul Tudor Jones sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 14,537 shares — an estimated $99.9K sold.

Paul Tudor Jones first reported a position in IGMS in Q4 2020 and held it in 6 quarters. The position peaked at $391K in Q1 2022. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Paul Tudor Jones reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 14,537 IGM Biosciences shares in Q3 2024, an estimated $99.9K.
  • Paul Tudor Jones first reported a position in IGM Biosciences in Q4 2020 and held it in 6 quarters.
  • Paul Tudor Jones's IGM Biosciences position peaked at $391K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.